[1] 张城铭,段王平,马永胜,等.同种异体骨软骨移植治疗软骨损伤的历史[J].实用骨科杂志,2024,30(1):2-6.
[2] Widuchowski W,Widuchowski J,Trzaska T.Articular cartilage defects:Study of 25,124 knee arthroscopies[J].Knee,2007,14(3):177-182.
[3] Shasha N,Aubin Phil P,Cheah HK, et al .Long-term clinical experience with fresh osteochondral allografts for articular knee defects in high demand patients [J].Cell and Tissue Banking,2002,3(3):175-182.
[4] Krych AJ,Robertson CM,Williams RJ 3rd.Cartilage study group.return to athletic activity after osteochondral allograft transplantation in the knee [J].Am J Sports Med,2012,40(5):1053-1059.
[5] Oladeji LO,Cook JL,Stannard JP, et al .Large fresh osteochondral allografts for the hip:Growing the evidence [J].Hip Int,2018,28(3):284-290.
[6] 王鹏飞,姜文学,新鲜同种异体骨软骨移植技术的研究进展[J].实用器官移植电子杂志,2019,7(4):6.
[7] Fischer SA,LuK.AST Infectious diseases community of practice.Screening of donor and recipient in solid organ transplantation[J].Am J Transplant,2013,13(Suppl 4):9-21.
[8] 中国医药教育协会感染疾病专业委员会.感染相关生物标志物临床意义解读专家共识[J].中华结核和呼吸杂志,2017,40(4):243-257.
[9] Fischer SA,LuK AST.Infectious diseases community of practice.screening of donor and recipient in solid organ transplantation[J].Am J Transplant,2013,13(Suppl 4):9-21.[10] FishmanJA,GrossiPA.Donor-derived infection:The challenge for transplant safety[J].Nat Rev Nephrol,2014,10(11):663-672.
[11] Ison MG,Nalesnik MA.An update on donor-derived disease transmission in organ transplantation[J].Am J Transplant,2011,11(6):1123-1130.
[12] Schubert T,Elisa Bigaré,Isacker TV, et al .Analysis of predisposing factors for contamination of bone and tendon allografts[J].Cell Tissue Bank,2012,13(3):421-429.
[13] 王辉,马筱玲,宁永忠,等.细菌与真菌涂片镜检和培养结果报告规范专家共识[J].中华检验医学杂志,2017,40(1):17-30.
[14] Torrie AM,Kesler WW,Elkin J, et al .Osteochondral allograft[J].Curr Rev Musculoskelet Med,2015,8(4):413-422.
[15] 窦科峰,陶开山,李霄,等.异种移植临床研究指导意见[J].器官移植,2018,9(6):7-10.
[16] 中华人民共和国卫生部.医疗机构管理条例实施细则 [J].中国卫生法制,1994(10):32-41.